Clinical Trials
5 trialsNCT03831932 2026-05-28
Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT06982222 2026-05-13
Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
Phase 1 Not yet recruiting
NCT00006382 2015-05-05
Lung Screening Study
National Cancer Institute (NCI)
Phase NA Completed
NCT01344005 2013-08-26
Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years
National Cancer Institute (NCI)
Phase NA Unknown
NCT00006087 2009-02-09
Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer
National Cancer Institute (NCI)
Phase NA Unknown